University of Minnesota Medical School researchers have developed a new strategy to improve the development of induced pluripotent stem cells (iPS).
Currently, iPS cells are created by introducing four defined genes to an adult cell. The genes reprogram the adult cell into a stem cell, which can differentiate into many different types of the cells in the body. Typically, the four genes introduced are Oct4, Sox2, Klf4 and c-Myc, a combination known as OSKM.
The U of M researchers found that by fusing two proteins – a master stem cell regulator (Oct4) and a fragment of a muscle cell inducer (MyoD) – they succeeded in “powering up” the stem cell regulator, which can dramatically improve the efficiency and purity of reprogrammed iPS cells.
“Our team discovered that by fusing a fragment of the powerful protein MyoD to Oct4 we could create a ‘super gene’ which would improve the iPS reprogramming process,” said senior author Dr. Nobuaki Kikyo, Stem Cell Institute researcher and University of Minnesota Medical School associate professor. “The result is what we termed M3O, or ‘super Oct4’ – a gene that improves the creation of iPS cells in a number of ways. In the process we shed new light on the mechanism of making iPS cells.”
Continue reading ‘Researchers improve method to create induced pluripotent stem cells’
Incoming search terms:
hirai kikyo iPS, ips cells news, Published News Upcoming News Submit a New Story Groups deaf vp, role of oskm, researchers develop new technique for creating stem cells, techniques to generate pluripotent stem cells, oct4 reprogramming cancer, iPS cells in cancer research, ips cells in cancer, ips cells from cancer cells, Published News Upcoming News Submit a New Story Groups alabama car accident, myoD iPS, proposed mechanism for oskm, protein reprogramed iPS cell 2011, problems with ipscs tumour development, problem with ipscs, model cancer stem cell with induced pluripotent stem cell, MyoD-oct, Myod1 induced pluripotent stem cell, nobuaki kikyo, nobuaki kikyo lab nih, oct4 myod, oct4 myod stem cell, oskm cnio, oskm in blood cells, pluripotent stem cell iPS news, recent iPS Cell news, reprogram cancer cell into iPS cells, super OCT4, tips for reprogramming ips, tumor and stem cells and ips, tumor cell iPS, what percentage of ips cells succeed, tumore ips cells, use of ips cells and cancer development, Ways to generate pluripotent stem cells, what combernation of genes make ipscells, self method to enhance stem cell, SCD Hirai, sanger human ips cells, reprogramming cancer cells, reprogramming cancer stem cell, reprogramming cancer stem cell to induced pluripotent stem cell, reprogramming generates tumors.